BDBM287967 N-(2,2-di(pyridin-4-yl)ethyl)-2-(4- (dimethylamino)phenyl)quinazolin-4- amine::US10087148, Example 34
SMILES: CN(C)c1ccc(cc1)-c1nc(NCC(c2ccncc2)c2ccncc2)c2ccccc2n1
InChI Key: InChIKey=YCIQXKQHYSRLKP-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium-dependent dopamine transporter (Homo sapiens (Human)) | BDBM287967 (N-(2,2-di(pyridin-4-yl)ethyl)-2-(4- (dimethylamino...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 21 | n/a | n/a | 7.4 | n/a |
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTE OF HEALTH; SOUTHERN RESEARCH INSTITUTE US Patent | Assay Description Uptake inhibition assay for the dopamine transporter was conducted in rat brain synaptosomes as described elsewhere with minor modifications (Rothman... | US Patent US10087148 (2018) BindingDB Entry DOI: 10.7270/Q27W6F63 | |||||||||||
More data for this Ligand-Target Pair |